Innovating Works

WEHI

Desconocido
CoMAnD: Contribution of the Epstein-Barr Virus and the Tumour Microenvironment to Anti-Apoptotic Mechanisms... THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH PUBLIC COMPANYLIMITED BY GUARANTEE participó en un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Diffuse large B-cell lymphoma (DLBCL) accounts for over one-third of lymphomas and is fatal in up to 40% of cases. Particularly poor surviva...
2022-05-30 - 2026-01-02 | Financiado
PvSTATEM: SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADA... THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH PUBLIC COMPANYLIMITED BY GUARANTEE participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 P. vivax is considered the most difficult human malaria to eliminate because of the inability of conventional diagnostics to detect individu...
2022-05-24 - 2027-09-30 | Financiado
BRCANCER: A novel approach for modeling development of breast cancer THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH PUBLIC COMPANYLIMITED BY GUARANTEE participó en un H2020: H2020-MSCA-IF-2015 Inheriting one mutant copy of the BRCA1 or BRCA2 gene is associated with a significant increased risk for developing aggressive and difficul...
2016-09-01 - 2018-07-03 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.